BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11156628)

  • 1. Inherited predisposition to pancreatic cancer.
    Efthimiou E; Crnogorac-Jurcevic T; Lemoine NR; Brentnall TA
    Gut; 2001 Feb; 48(2):143-7. PubMed ID: 11156628
    [No Abstract]   [Full Text] [Related]  

  • 2. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
    Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
    Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of germline genetic mutations in patients with pancreatic cancer.
    Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
    Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineating the effects BRCA1 and BRCA2 loss of heterozygosity in pancreatic cancer progression.
    Fam HK
    Clin Genet; 2014 Jan; 85(1):18-20. PubMed ID: 24147435
    [No Abstract]   [Full Text] [Related]  

  • 5. Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor.
    Goehringer C; Sutter C; Kloor M; Gebert J; Slater EP; Keller M; Treiber I; Ganschow P; Kadmon M; Moog U
    Fam Cancer; 2017 Apr; 16(2):303-309. PubMed ID: 27838800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of genetic variants with pancreatic cancer.
    Skudra S; Stāka A; Puķītis A; Siņicka O; Pokrotnieks J; Nikitina M; Tracums J; Tihomirova L
    Cancer Genet Cytogenet; 2007 Nov; 179(1):76-8. PubMed ID: 17981219
    [No Abstract]   [Full Text] [Related]  

  • 7. Genotype/phenotype of familial pancreatic cancer.
    Brand RE; Lynch HT
    Endocrinol Metab Clin North Am; 2006 Jun; 35(2):405-15, xi. PubMed ID: 16632102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.
    Vasen HF; Wasser M; van Mil A; Tollenaar RA; Konstantinovski M; Gruis NA; Bergman W; Hes FJ; Hommes DW; Offerhaus GJ; Morreau H; Bonsing BA; de Vos tot Nederveen Cappel WH
    Gastroenterology; 2011 Mar; 140(3):850-6. PubMed ID: 21129377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of pancreatic cancer: where are we now? Where are we going?
    Del Chiaro M; Boggi U; Presciuttini S; Bertacca L; Croce C; Mosca I; Mosca F
    JOP; 2005 Jan; 6(1 Suppl):60-7. PubMed ID: 15650288
    [No Abstract]   [Full Text] [Related]  

  • 10. A carrier of both MEN1 and BRCA2 mutations: case report and review of the literature.
    Ghataorhe P; Kurian AW; Pickart A; Trapane P; Norton JA; Kingham K; Ford JM
    Cancer Genet Cytogenet; 2007 Dec; 179(2):89-92. PubMed ID: 18036394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic basis of sporadic pancreatic cancer.
    Baumgart M; Heinmöller E; Horstmann O; Becker H; Ghadimi BM
    Cell Oncol; 2005; 27(1):3-13. PubMed ID: 15750203
    [No Abstract]   [Full Text] [Related]  

  • 12. Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis.
    Evans JP; Burke W; Chen R; Bennett RL; Schmidt RA; Dellinger EP; Kimmey M; Crispin D; Brentnall TA; Byrd DR
    J Med Genet; 1995 May; 32(5):330-5. PubMed ID: 7616537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there any relationship between BRCA1 gene mutation and pancreatic cancer development?
    Lawniczak M; Gawin A; Białek A; Lubiński J; Starzyńska T
    Pol Arch Med Wewn; 2008 Nov; 118(11):645-9. PubMed ID: 19140568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal adenocarcinoma of the pancreas in MEN-1-patients.
    Bordi C; Brandi ML
    Virchows Arch; 1998 Apr; 432(4):385-6. PubMed ID: 9565350
    [No Abstract]   [Full Text] [Related]  

  • 15. Familial pancreatic cancer syndromes.
    Habbe N; Langer P; Sina-Frey M; Bartsch DK
    Endocrinol Metab Clin North Am; 2006 Jun; 35(2):417-30, xi. PubMed ID: 16632103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of genetic factors in the etiology of pancreatic adenocarcinoma: an update.
    Chappuis PO; Ghadirian P; Foulkes WD
    Cancer Invest; 2001; 19(1):65-75. PubMed ID: 11291558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cancer surveillance: learning as we go.
    Brentnall TA
    Am J Gastroenterol; 2011 May; 106(5):955-6. PubMed ID: 21540900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary pancreatic adenocarcinoma. A clinical perspective.
    Brand RE; Lynch HT
    Med Clin North Am; 2000 May; 84(3):665-75. PubMed ID: 10872423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of BRCA1 and BRCA2 mutations in pancreatic cancer.
    Greer JB; Whitcomb DC
    Gut; 2007 May; 56(5):601-5. PubMed ID: 16973716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.